Book chapters

Elsevier,

Alzheimer’s Disease: Understanding Biomarkers, Big Data, and Therapy, Volume , 1 January 2021

This book chapter advances SDG #3 and #10 by outlining the applications of big data to Alzheimer’s disease research as well as common methods used to collect and analyze big data. It also explores how big data research could be used to treat, diagnose, and understand Alzheimer’s disease.
Elsevier,

Alzheimer’s Disease: Understanding Biomarkers, Big Data, and Therapy, Volume , 1 January 2021

This book chapter advances SDG #3 and #10 by providing evidence that behavioral treatments are more effective than most pharmacological therapies at managing depression in Alzheimer’s disease.
Elsevier,

Handbook of Clinical Neurology, Volume 179, January 2021

This book chapter advances SDG #3 and #10 by reviewing the observed epidemiological links between normal and abnormal diurnal and seasonal rhythmicity, cognitive impairment, and ADRD. Then reviewing normal diurnal and seasonal rhythms of brain epigenetic modification and gene expression in model organisms. Finally, reviewing evidence for diurnal and seasonal rhythms of epigenetic modification and gene expression the human brain in aging, Alzheimer's disease, and other brain disorders.
Elsevier,

Sex and Gender Differences in Alzheimer’s Disease, Volume , 1 January 2021

This book chapter advances SDG #3 and #10 by stressing that a population health approach and a focus on promoting equity in health and access to care are critical to reducing the risk of AD and other dementias.
Elsevier,

Alzheimer’s Disease: Understanding Biomarkers, Big Data, and Therapy, Volume , 1 January 2021

This book chapter advances SDG #3 and #10 by presenting that (1) some of these depression scales do not correlate, suggesting that they assess different aspects of depression; (2) reports of depression in dementia vary based on depression in dementia scale used; and (3) severe memory impairment may impact the ability to assess depression in the patients using self-reports.
Elsevier,

Autophagy in Health and Disease, Volume , 1 January 2021

This book chapter advances SDG #3 and #10 by reviewing the extant literature on autophagy in AD and covers recent progress on the molecular mechanisms of NAD+-dependent mitophagy/autophagy regulation and mechanisms underlying the anti-AD potential of NAD+. Further studies to define the NAD+-mitophagy/autophagy axis may shed light on novel therapeutics to treat AD and potentially provide insights into other neurodegenerative diseases.
Elsevier,

Assessments, Treatments and Modeling in Aging and Neurological Disease: The Neuroscience of Aging, Volume , 1 January 2021

This book chapter advances SDG #3 and #10 by reviewing the use of nonhuman primates as a viable model of aging and neurodegeneration research.
Elsevier,

International Review of Neurobiology, Volume 159, January 2021

This book chapter advances SDG #3 and #10 by reviewing deep brain stimulation as a treatment for AD patients, reviewing the recent studies and issues associated with the treatment.
Elsevier,

Materials and the Environment (Third Edition): Chapter 2 - Resource consumption and its drivers, Volume , 2021.

This book chapter advances SDG 12 by summarizing the orders of magnitude of the flow of materials, energy and water that material production entails.
Elsevier,

Materials and the Environment, Third Edition: Chapter 11 - Renewable materials, natural materials, Volume , 2021

This book chapter advances SDGs 9 and 12 by exploring whether renewable materials, derived wholly or in part from nature, can play a larger role in the engineering economy of the 21st century.

Pages